According to GlobalData’s medical device pipeline database, 31 Bone Cement devices are in various stages of development globally. GlobalData’s report Bone Cement provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 14 are in active development, while the remaining 18 are in an inactive stage of development. There are ten products in the early stages of development, and the remaining four are in the late stages of development.
Bone cement is a fixing material used to fill in spaces between an orthopedic prosthesis and the bone stock. Bone cement helps restore functionality, provides elasticity to the zone between the prosthesis and the bone stock and maintains the mechanical stability of the prosthesis. Bone cement is composed of two components: PMMA (Polymethyl methacrylate) amorphous powder and MMA (methyl methacrylate) liquid stabilizer. One unit of bone cement consists of a single dosage or 40 grams of powder. This category includes both antibiotic and nonantibiotic bone cement.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Bone Cement pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Bone Cement devices. Overall, most of these Bone Cement pipeline devices are being developed by private entities.
Key players involved in the active development of Bone Cement include Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of Limerick, Graftys, Hyalex Orthopaedics, Inossia, Maxigen Biotech, Moroxite F, National University of Science and Technology MISIS, Onbone and OSARTIS.
For a complete picture of the developmental pipeline for Bone Cement devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
